{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.199.11.1042","meta":{"versionId":"17","lastUpdated":"2017-05-04T01:00:13.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2017-05-04"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1042","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.199.11.1042"}],"version":"20170504","name":"AnaphylacticReactionToInactivatedPolioVaccineIPV","title":"Anaphylactic Reaction to Inactivated Polio Vaccine (IPV)","status":"active","experimental":false,"date":"2017-05-04T01:00:13-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"293117006","display":"Poliomyelitis vaccine adverse reaction (disorder)"}]}]},"expansion":{"identifier":"urn:uuid:dd906983-fb8a-422e-92ea-90fc20b817e5","timestamp":"2023-12-11T02:41:00-05:00","total":1,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"293117006","display":"Adverse reaction to component of vaccine product containing Human poliovirus antigen (disorder)"}]}}